Chih-Hao Chang

Chih-Hao Chang

Auto-generated profile, based on publicly available information

Chih-Hao Chang

The Jackson Laboratory

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2015 in Cell
Verified
Journal Article
Closed access
CCChih-Hao Chang
Chih-Hao Chang
JQJing Qiu
Jing Qiu
DODavid O’sullivan
David O’sullivan
MBMichael D. Buck
Michael D. Buck
TNTakuro Noguchi
Takuro Noguchi
EPErika L. Pearce
Erika L. Pearce

1 June 2013 in Cell
Verified
Journal Article
Closed access
CCChih-Hao Chang
Chih-Hao Chang
JCJonathan D. Curtis
Jonathan D. Curtis
Leonard B. MaggiLeonard B. Maggi
Leonard B. Maggi
BFBrandon Faubert
Brandon Faubert
AVAlejandro V. Villarino
Alejandro V. Villarino
EPErika L. Pearce
Erika L. Pearce

23 February 2014 in Nature Immunology
Verified
Journal Article
Closed access
PDF file
BEBart Everts
Bart Everts
EAEyal Amiel
Eyal Amiel
SHStanley Ching-Cheng Huang
Stanley Ching-Cheng Huang
ASAmber M Smith
Amber M Smith
CCChih-Hao Chang
Chih-Hao Chang
EPEdward J Pearce
Edward J Pearce

22 March 2016 in Nature Immunology
Verified
Journal Article
Closed access
PDF file
CCChih-Hao Chang
Chih-Hao Chang
EPErika L Pearce
Erika L Pearce

18 July 2020 in Immunology
Verified
Journal Article
Open access
PDF file
JSJohn D. Sears
John D. Sears
KWKevin J. Waldron
Kevin J. Waldron
JWJian Wei
Jian Wei
CCChih‐Hao Chang
Chih‐Hao Chang
Summary: CD8 T‐cells are an essential component of the adaptive immune response accountable for the clearance of virus‐infected cells via cytotoxic effector functions. Maintaining a specific metabolic profile is necessary for these T‐cells to sustain their effector functions and clear pathogens. When CD8 T‐cells are activated via T‐cell receptor recognition of viral antigen, they transition from a naïve to an effector state and eventually to a memory phenotype, and their metabolic profiles shift as the cells differentiate to accomidate different metabolic demands. However, in the context of particular chronic viral infections (CVIs), CD8 T‐cells can become metabolically dysfunctional in a state known as T‐cell exhaustion. In this state, CD8 T‐cells exhibit reduced effector functions and are unable to properly control pathogens. Clearing these chronic infections becomes progressively difficult as increasing numbers of the effector T‐cells become exhausted. Hence, reversal of this dysfunctional metabolic phenotype is vital when considering potential treatments of these infections and offers the opportunity for novel strategies for the development of therapies against CVIs. In this review we explore research implicating alteration of the metabolic state as a means to reverse CD8 T‐cell exhaustion in CVIs. These findings indicate that strategies targeting dysfunctional CD8 T‐cell metabolism could prove to be a promising option for successfully treating CVIs.

27 July 2023 in iScience
Verified
Journal Article
Open access
JWJohn J. Wilson
John J. Wilson
JWJian Wei
Jian Wei
ADAndrea R. Daamen
Andrea R. Daamen
JSJohn D. Sears
John D. Sears
EBElaine Bechtel
Elaine Bechtel
CCChih-Hao Chang
Chih-Hao Chang
Aberrant metabolic demand is observed in immune/inflammatory disorders, yet the role in pathogenesis remains unclear. Here, we discover that in lupus, activated B cells, including germinal center B (GCB) cells, have remarkably high glycolytic requirement for survival over T cell populations, as demonstrated by increased metabolic activity in lupus-activated B cells compared to immunization-induced cells. The augmented reliance on glucose oxidation makes GCB cells vulnerable to mitochondrial ROS-induced oxidative stress and apoptosis. Short-term glycolysis inhibition selectively reduces pathogenic activated B in lupus-prone mice, extending their lifespan, without affecting T follicular helper cells. Particularly, BCMA-expressing GCB cells rely heavily on glucose oxidation. Depleting BCMA-expressing activated B cells with APRIL-based CAR-T cells significantly prolongs the lifespan of mice with severe autoimmune disease. These results reveal that glycolysis-dependent activated B and GCB cells, especially those expressing BCMA, are potentially key lupus mediators, and could be targeted to improve disease outcomes.